Reprogramming a patient's eye cells may herald new treatments against degenerative disease

Oct 22, 2009

Scientists have overcome a key barrier to the clinical use of stem cells with a technique which transforms regular body cells into artificial stem cells without the need for introducing foreign genetic materials, which could be potentially harmful. The research, published in Stem Cells, suggests that cells taken from a patient's eye can be "reprogrammed" to replace or restore cells lost to degenerative diseases.

The research, led by Professor Iqbal Ahmad and co-authors from the University of Nebraska Medical Center, is the first proof in principle that somatic, or body cells, can be reprogrammed into induced pluripotent (iPSCs) simply through the influence of the microenvironment in which the sampled cells are cultured. Until now genetic materials were introduced into somatic cells to re-programme them to become pluripotent, enabling them to generate cells of all three embryonic lineages.

"Our findings provide evidence for an emerging view that somatic cells may be reprogrammed safely and simply by defined chemicals and other factors, which may facilitate their clinical use," said Ahmad. "The next step is to know how robust the reprogramming is and what existed within the microenvironment to cause it."

The team sampled progenitor eye cells, which regenerate the eye's cornea, from laboratory rats. By reprogramming them to resemble stem cells they acquired the properties necessary to replace or restore neurons, cardiomyocytes, and hepatocytes, cell types which are degenerated in Parkinson's disease, heart disease, and .

This reprogramming technique may allow 'autologous cell transplantation', where the donor of the cells is also the recipient. This is preferable to using cells from another person which may cause the patient's immune system to reject the transplanted cells.

Also, because this technique involves the use of iPSCs derived from adult and not (ES) it side steps many of the ethical dilemmas which have embroiled stem cell research.

"This research shows that it is possible to take cells from a patient's eye without affecting vision and reprogram them for use in autologous cell therapy to replace or rescue degenerating cells," concluded Ahmad, "this would allow us to circumvent ethical issues and the problems caused by the immune system rejecting foreign cells."

Source: Wiley (news : web)

Explore further: York's anti-malarial plant given Chinese approval

Related Stories

New technique produces genetically identical stem cells

Jul 01, 2008

Adult cells of mice created from genetically reprogrammed cells—so-called induced pluripotent stem (IPS) stem cells—can be triggered via drug to enter an embryonic-stem-cell-like state, without the need for further genetic ...

Recommended for you

How an RNA gene silences a whole chromosome

17 hours ago

Researchers at Caltech have discovered how an abundant class of RNA genes, called long non-coding RNAs (lncRNAs, pronounced link RNAs) can regulate key genes. By studying an important lncRNA, called Xist, ...

Single cells seen in unprecedented detail

19 hours ago

Researchers have developed a large-scale sequencing technique called Genome and Transcriptome Sequencing (G&T-seq) that reveals, simultaneously, the unique genome sequence of a single cell and the activity ...

York's anti-malarial plant given Chinese approval

Apr 24, 2015

A new hybrid plant used in anti-malarial drug production, developed by scientists at the University of York's Centre for Novel Agricultural Products (CNAP), is now registered as a new variety in China.

The appeal of being anti-GMO

Apr 24, 2015

A team of Belgian philosophers and plant biotechnologists have turned to cognitive science to explain why opposition to genetically modified organisms (GMOs) has become so widespread, despite positive contributions ...

User comments : 1

Adjust slider to filter visible comments by rank

Display comments: newest first

fixer
not rated yet Oct 23, 2009
All research to help the blind is good.
Will this also tie in with Mac D & Ret Pigmentosa stem cell research also reported hereabouts?

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.